IDEAYA Biosciences, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-113.7M | $-274.5M | $-113.0M | $-58.7M | $-49.8M | $-34.5M | $-42.0M | $-34.3M |
| Depreciation & Amortization | $2.7M | $2.4M | $2.5M | $2.1M | $1.7M | $1.4M | $1.2M | $886.0K |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $46.1M | $34.7M | $18.5M | $11.6M | $8.2M | $3.6M | $2.2M | $950.0K |
| Net Cash from Operating Activities | $-71.1M | $-247.6M | $-115.2M | $-87.2M | $-55.8M | $55.5M | $-39.3M | $-27.6M |
| Investing Activities | ||||||||
| Capital Expenditures | $2.4M | $3.9M | $2.4M | $3.4M | $2.6M | $493.0K | $1.4M | $1.7M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $70.0M | $-502.6M | $-158.5M | $-33.4M | $-69.7M | $-146.2M | $2.3M | $-63.2M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $29.8M | $677.6M | $362.7M | $97.2M | $145.5M | $128.8M | $50.6M | $105.4M |
| Net Change in Cash | $28.7M | $-72.6M | $89.0M | $-23.4M | $20.0M | $38.0M | $13.6M | $14.6M |
| Free Cash Flow | $-73.5M | $-251.4M | $-117.6M | $-90.6M | $-58.4M | $55.0M | $-40.7M | $-29.3M |